Table of Contents

Reviews

• Open Access

  Targeted screening programmes in COPD: how to identify individuals with α₁-antitrypsin deficiency

  Joanna Chorostowska-Wynimko

  European Respiratory Review 24 (135) 40-45; DOI: 10.1183/09059180.00010614 Published 28 February 2015

  • Disclosures
• Open Access

  Long-term experience in the treatment of α₁-antitrypsin deficiency: 25 years of augmentation therapy

  Helmut Teschler

  European Respiratory Review 24 (135) 46-51; DOI: 10.1183/09059180.10010714 Published 28 February 2015

  • Disclosures
• Open Access

  Diagnosing α₁-antitrypsin deficiency: how to improve the current algorithm

  Noel G. McElvaney

  European Respiratory Review 24 (135) 52-57; DOI: 10.1183/09059180.10010814 Published 28 February 2015

  • Disclosures
• Open Access

  Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis

  Vincent Cottin, Toby Maher

  European Respiratory Review 24 (135) 58-64; DOI: 10.1183/09059180.00011514 Published 28 February 2015

  • Disclosures
• Open Access

  The changing treatment landscape in idiopathic pulmonary fibrosis

  Ulrich Costabel

  European Respiratory Review 24 (135) 65-68; DOI: 10.1183/09059180.00011414 Published 28 February 2015

  • Disclosures
• Open Access

  The multidisciplinary approach in the diagnosis of idiopathic pulmonary fibrosis: a patient case-based review

  Sara Tomassetti, Sara Piciucchi, Paola Tantalocco, Alessandra Dubini, Venerino Poletti

  European Respiratory Review 24 (135) 69-77; DOI: 10.1183/09059180.00011714 Published 28 February 2015

  • Disclosures
• Open Access

  Host–microbe interactions in distal airways: relevance to chronic airway diseases

  Clémence Martin, Pierre-Régis Burgel, Patricia Lepage, Claire Andréjak, Jacques de Blic, Arnaud Bourdin, Jacques Brouard, Pascal Chanez, Jean-Charles Dalphin, Gaetan Deslée, Antoine Deschildre, Philippe Gosset, Lhousseine Touqui, Daniel Dusser

  European Respiratory Review 24 (135) 78-91; DOI: 10.1183/09059180.00011614 Published 28 February 2015

  • Disclosures
• Open Access

  Volatile organic compounds and risk of asthma and allergy: a systematic review

  Ulugbek B. Nurmatov, Nara Tagiyeva, Sean Semple, Graham Devereux, Aziz Sheikh

  European Respiratory Review 24 (135) 92-101; DOI: 10.1183/09059180.00000714 Published 28 February 2015

  • Supplementary material
  • Disclosures
• Open Access

  Cellular interactions in the pathogenesis of interstitial lung diseases

  Gianluca Bagnato, Sergio Harari

  European Respiratory Review 24 (135) 102-114; DOI: 10.1183/09059180.00003214 Published 28 February 2015

  • Supplementary material
• Open Access

  Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic

  Oluf Dimitri Røe, Giulia Maria Stella

  European Respiratory Review 24 (135) 115-131; DOI: 10.1183/09059180.00007014 Published 28 February 2015